Connor, Clark & Lunn Investment Management (CC&L)’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,450
Closed -$205K 990
2017
Q2
$205K Buy
+11,450
New +$214K ﹤0.01% 743
2017
Q1
Sell
-10,200
Closed -$256K 1063
2016
Q4
$256K Buy
+10,200
New +$241K ﹤0.01% 746
2014
Q4
Sell
-62,800
Closed -$785K 672
2014
Q3
$785K Buy
62,800
+22,200
+55% +$310K 0.01% 339
2014
Q2
$592K Buy
40,600
+30,400
+298% +$397K ﹤0.01% 374
2014
Q1
$136K Buy
+10,200
New +$117K ﹤0.01% 645
2013
Q3
Sell
-13,200
Closed -$125K 609
2013
Q2
$125K Buy
+13,200
New +$133K ﹤0.01% 494

Other funds holding OME

Connor, Clark & Lunn Investment Management (CC&L)'s OME Position: Q3 2017 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Omega Protein (OME) in Q3 2017, closing a stake of 11,450 shares — an estimated $205K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OME in Q2 2013 and held it in 6 quarters. The position peaked at $785K in Q3 2014. 122 funds tracked by Wall St. Rank hold OME as of Q3 2017.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Omega Protein position as of Q3 2017 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 11,450 Omega Protein shares in Q3 2017, an estimated $205K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Omega Protein in Q2 2013 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Omega Protein position peaked at $785K in Q3 2014.
  • 122 funds tracked by Wall St. Rank held Omega Protein as of Q3 2017.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2017, filed 14 Nov 2017.